Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
MeSH Unique Identifier
|
| https://www.w3.org/2000/01/rdf-schema#label |
MeSH:D014839
|
| gptkbp:MeSH_ID |
D014839
Pharmacologic Vasoconstrictor Agents Vasoconstrictor Agents, Pharmacologic Vasoconstrictor Drugs Vasoconstrictors |
| gptkbp:MeSH_term_name |
Vasoconstrictor Agents
|
| gptkbp:MeSH_tree_number |
C07.465.815
D27.505.954.122.500 |
| gptkbp:pharmacological_action |
Vasoconstrictor Agent
|
| gptkbp:relatedConcept |
Vasodilation
Vasodilator Agents |
| gptkbp:scope |
Drugs used to cause constriction of the blood vessels.
|
| gptkbp:seeAlso |
gptkb:Norepinephrine
gptkb:Phenylephrine gptkb:Pseudoephedrine Epinephrine Phenylpropanolamine Adrenergic alpha-Agonists Ephedrine Ergot Alkaloids Mephentermine Metaraminol Methoxamine Midodrine Oxymetazoline Tetrahydrozoline Vasopressins Xylometazoline |
| gptkbp:bfsParent |
gptkb:von_Hippel-Lindau_disease
|
| gptkbp:bfsLayer |
7
|